2019
DOI: 10.12688/gatesopenres.12890.2
|View full text |Cite
|
Sign up to set email alerts
|

Accessing DMPA-SC through the public and private sectors in Nigeria: users’ characteristics and their experiences

Abstract: Background: Beginning in 2015, subcutaneous depot medroxyprogesterone acetate (DMPA-SC) was added to the contraceptive method mix in Nigeria, primarily through social marketing in the private sector and community-based distribution in the public sector. We compare user experiences in acquiring DMPA-SC across sectors during this national scale-up. Methods: From October 2017 to February 2018, 459 women (Npublic=235; Nprivate=224) completed a phone survey from a convenience sample of 1,444 women (Npublic=912; Npr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 29 publications
0
4
0
Order By: Relevance
“…11 22 Nigeria tackled both private and public sector delivery, using innovative supply-side solutions such as targeting high-volume contraceptive service facilities and in-facility trainings for providers. 18 23 The country's national guidelines for selfinjection involve several visits to the provider to achieve proficiency before a user is given doses to self-administer without health provider supervision. 24 In comparison, the roll-out of DMPA-SC in Kenya has been delayed and only recently expanded to public health facilities countrywide; self-injection has not yet been approved within this context.…”
Section: Self-injection Is Fairly Unknown To Women In These Contextsmentioning
confidence: 99%
“…11 22 Nigeria tackled both private and public sector delivery, using innovative supply-side solutions such as targeting high-volume contraceptive service facilities and in-facility trainings for providers. 18 23 The country's national guidelines for selfinjection involve several visits to the provider to achieve proficiency before a user is given doses to self-administer without health provider supervision. 24 In comparison, the roll-out of DMPA-SC in Kenya has been delayed and only recently expanded to public health facilities countrywide; self-injection has not yet been approved within this context.…”
Section: Self-injection Is Fairly Unknown To Women In These Contextsmentioning
confidence: 99%
“…It is against this background that the Children Investment Fund Foundation funded the Delivering Innovation in Self-Care project (2020–2024) in Uganda and Nigeria to support women to initiate, adopt, sustain use of, and advocate for SI as a cornerstone of sexual and reproductive healthcare among women in urban settings. Nigeria approved DMPA-SC for SI in 2016 while Uganda approved it in 2017 to leverage the popularity of injectables which remains to be the most popular method among married women [14] . In this study that was conducted as part of the formative phase of the Delivering Innovation in Self-Care project, data were collected from public sector health facilities among family planning clients in Uganda and Nigeria to develop a simple, visual information cascade that can be used to identify potential missed opportunities for the provision of SI information and counseling among women seeking FP services.…”
Section: Introductionmentioning
confidence: 99%
“…Routine information from the Health Management Information Systems (HMIS) or Logistics Management Information Systems (LMIS) are also lacking, with insufficient client characteristics, incomplete reporting from private facilities, and data aggregations that restrict client-level analysis [ 6 , 7 ]. The limited set of studies on supply-side factors mostly explore service provider-related characteristics and behaviors, with minimal or no data on method availability [8] , [9] , [10] , [11] . The Performance Monitoring for Action (PMA) project collects national data on DMPA-SC from service delivery points and a representative sample of women, but the few publications to date have largely focused on user characteristics [ 3 , 5 , 12 ].…”
Section: Introductionmentioning
confidence: 99%